Jorge Ferrer

15.5k total citations · 2 hit papers
104 papers, 6.6k citations indexed

About

Jorge Ferrer is a scholar working on Surgery, Genetics and Molecular Biology. According to data from OpenAlex, Jorge Ferrer has authored 104 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 72 papers in Surgery, 51 papers in Genetics and 49 papers in Molecular Biology. Recurrent topics in Jorge Ferrer's work include Pancreatic function and diabetes (71 papers), Diabetes and associated disorders (29 papers) and Genetics and Neurodevelopmental Disorders (24 papers). Jorge Ferrer is often cited by papers focused on Pancreatic function and diabetes (71 papers), Diabetes and associated disorders (29 papers) and Genetics and Neurodevelopmental Disorders (24 papers). Jorge Ferrer collaborates with scholars based in Spain, United Kingdom and United States. Jorge Ferrer's co-authors include M.A. Maestro, Sylvia F. Boj, Joan‐Marc Servitja, Marcelina Párrizas, Andrew T. Hattersley, Sian Ellard, Harry Heimberg, Nadya Dimitrova, Carina Cardalda and Xiaobo Xu and has published in prestigious journals such as Nature, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Jorge Ferrer

100 papers receiving 6.6k citations

Hit Papers

Beta Cell Hubs Dictate Pancreatic Islet Responses to Glucose 2016 2026 2019 2022 2016 2024 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jorge Ferrer Spain 43 4.0k 3.4k 2.6k 1.6k 635 104 6.6k
Anna L. Gloyn United Kingdom 47 5.0k 1.3× 3.7k 1.1× 3.3k 1.2× 3.4k 2.2× 557 0.9× 140 8.0k
Pedro L. Herrera Switzerland 60 7.2k 1.8× 4.4k 1.3× 4.5k 1.7× 3.7k 2.4× 411 0.6× 133 10.2k
Nils Billestrup Denmark 48 2.3k 0.6× 3.0k 0.9× 1.8k 0.7× 3.2k 2.1× 604 1.0× 125 7.2k
Mark Van de Casteele Belgium 31 2.7k 0.7× 2.0k 0.6× 1.6k 0.6× 1.3k 0.8× 166 0.3× 71 4.0k
Gabriela da Silva Xavier United Kingdom 34 2.4k 0.6× 2.4k 0.7× 832 0.3× 1.1k 0.7× 383 0.6× 62 3.9k
Patrice Denèfle France 35 2.4k 0.6× 2.6k 0.8× 617 0.2× 757 0.5× 537 0.8× 69 4.9k
Matthias Braun United Kingdom 32 2.6k 0.6× 1.9k 0.6× 902 0.3× 1.3k 0.8× 504 0.8× 48 4.1k
Ingo B. Leibiger Sweden 36 2.4k 0.6× 2.1k 0.6× 1.2k 0.5× 1.2k 0.8× 129 0.2× 91 4.3k
Andrew Plump United States 31 2.7k 0.7× 3.7k 1.1× 806 0.3× 1.2k 0.8× 961 1.5× 42 9.1k
Carina Ämmälä Sweden 28 2.5k 0.6× 3.0k 0.9× 671 0.3× 1.1k 0.7× 221 0.3× 42 5.0k

Countries citing papers authored by Jorge Ferrer

Since Specialization
Citations

This map shows the geographic impact of Jorge Ferrer's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jorge Ferrer with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jorge Ferrer more than expected).

Fields of papers citing papers by Jorge Ferrer

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jorge Ferrer. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jorge Ferrer. The network helps show where Jorge Ferrer may publish in the future.

Co-authorship network of co-authors of Jorge Ferrer

This figure shows the co-authorship network connecting the top 25 collaborators of Jorge Ferrer. A scholar is included among the top collaborators of Jorge Ferrer based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jorge Ferrer. Jorge Ferrer is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Yamanaka, Takuya, Jorge Ferrer, Juan Antonio Solon, et al.. (2024). Health system costs of providing outpatient care for diabetes in people with TB in the Philippines. SHILAP Revista de lepidopterología. 1(3). 124–129.
2.
Wapnir, Irene, E. Shelley Hwang, Kelly K. Hunt, et al.. (2024). Abstract PO5-22-09: Positive pegulicianine fluorescence rate in the lumpectomy cavity correlates with tumor distance to margins in excised tissue. Cancer Research. 84(9_Supplement). PO5–22. 1 indexed citations
3.
Zaugg, Judith B., Pelin Sahlén, Robin Andersson, et al.. (2022). Current challenges in understanding the role of enhancers in disease. Nature Structural & Molecular Biology. 29(12). 1148–1158. 35 indexed citations
4.
Fukuda, Akihisa, Osamu Araki, Munemasa Nagao, et al.. (2022). Loss of Arid1a and Pten in Pancreatic Ductal Cells Induces Intraductal Tubulopapillary Neoplasm via the YAP/TAZ Pathway. Gastroenterology. 163(2). 466–480.e6. 16 indexed citations
5.
Rovira, Meritxell, M.A. Maestro, Vanessa Grau, & Jorge Ferrer. (2021). Hnf1b -CreER causes efficient recombination of a Rosa26-RFP reporter in duct and islet δ cells. Islets. 13(5-6). 134–139. 2 indexed citations
6.
Kalisz, Mark, Edgar Bernardo, Anthony Beucher, et al.. (2020). HNF1A recruits KDM6A to activate differentiated acinar cell programs that suppress pancreatic cancer. The EMBO Journal. 39(9). e102808–e102808. 46 indexed citations
7.
8.
Mitchell, Ryan K., David J. Hodson, Jorge Ferrer, et al.. (2016). Defective glucose homeostasis in mice inactivated selectively for Tcf7l2 in the adult beta cell with an Ins1-controlled Cre. Spiral (Imperial College London).
10.
Thorens, Bernard, David Tarussio, M.A. Maestro, et al.. (2014). Ins1 Cre knock-in mice for beta cell-specific gene recombination. Diabetologia. 58(3). 558–565. 153 indexed citations
11.
Jeliazkova, Petia, Simone Jörs, Marcel Lee, et al.. (2013). Canonical Notch2 signaling determines biliary cell fates of embryonic hepatoblasts and adult hepatocytes independent of Hes1. Hepatology. 57(6). 2469–2479. 73 indexed citations
12.
Allen, Hana Lango, Sarah E. Flanagan, Charles Shaw‐Smith, et al.. (2011). GATA6 haploinsufficiency causes pancreatic agenesis in humans. Nature Genetics. 44(1). 20–22. 207 indexed citations
13.
Gauthier, Benoit R., Andreas Wiederkehr, Mathurin Baquié, et al.. (2009). PDX1 Deficiency Causes Mitochondrial Dysfunction and Defective Insulin Secretion through TFAM Suppression. Cell Metabolism. 10(2). 110–118. 94 indexed citations
14.
Luco, Reini F., M.A. Maestro, Nicolas Sadoni, Daniele Zink, & Jorge Ferrer. (2008). Targeted Deficiency of the Transcriptional Activator Hnf1α Alters Subnuclear Positioning of Its Genomic Targets. PLoS Genetics. 4(5). e1000079–e1000079. 16 indexed citations
15.
Ramos‐Lopez, Elizabeth, Mercè Fernández-Balsells, Heinrich Kahles, et al.. (2007). HLA-DQ Haplotypes in Spanish and German Families with Graves' Disease: Contribution to DQA1*0501-DQB1*0301 Mediated Genetic Susceptibility from Fathers. Thyroid. 17(11). 1131–1135. 4 indexed citations
16.
Mellitzer, Georg, Stefan Bonné, Reini F. Luco, et al.. (2006). IA1 is NGN3‐dependent and essential for differentiation of the endocrine pancreas. The EMBO Journal. 25(6). 1344–1352. 145 indexed citations
17.
Maestro, M.A., Sylvia F. Boj, Reini F. Luco, et al.. (2003). Hnf6 and Tcf2 (MODY5) are linked in a gene network operating in a precursor cell domain of the embryonic pancreas. Human Molecular Genetics. 12(24). 3307–3314. 124 indexed citations
18.
Hansen, Sara K., Marcelina Párrizas, Štěpánka Průhová, et al.. (2002). Genetic evidence that HNF-1α–dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. Journal of Clinical Investigation. 110(6). 827–833. 77 indexed citations
19.
Hansen, Sara K., Marcelina Párrizas, Štěpánka Průhová, et al.. (2002). Genetic evidence that HNF-1α–dependent transcriptional control of HNF-4α is essential for human pancreatic β cell function. Journal of Clinical Investigation. 110(6). 827–833. 4 indexed citations
20.
Novials, Anna, et al.. (1989). Suppression by insulin treatment of the glucose-induced paradoxical inhibition of insulin release in Type 2 (non-insulin-dependent) diabetic patients. Diabetologia. 32. 523. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026